Lester J. Peters

Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck

Waun Ki Hong, S. M. Lippman, Loretta M. Itri et al. · New England Journal of Medicine · 1990 · 1.4K citations · Full text

Medicine, Oncology, Neoplasia +12

Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships

Howard D. Thames, H. Rodney Withers, Lester J. Peters et al. · International Journal of Radiation Oncology*Biology*Physics · 1982 · 843 citations

Medicine, Oncology, Radiation Oncology +16

Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02

Lester J. Peters, Brian O’Sullivan, J. Giralt et al. · Journal of Clinical Oncology · 2010 · 808 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Prognostic Significance of p16 ^INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial

Danny Rischin, Richard J. Young, Richard Fisher et al. · Journal of Clinical Oncology · 2010 · 741 citations · Full text

Medicine, Oncology, Radiation Oncology +12

Prognostic Significance of [¹⁸F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer Randomly Assigned to Chemoradiation With or Without Tirapazamine: A Substudy of Trans-Tasman Radiation Oncology Group Study 98.02

Danny Rischin, Rodney J. Hicks, Richard Fisher et al. · Journal of Clinical Oncology · 2006 · 543 citations · Full text

Medicine, Oncology, Radiation Oncology +17